Patent Assignment
Reel/Frame 057986/0119
Assignment of Assignor's Interest
Recorded: 2021-11-01
Pages: 6
Assignee
ENGMAB SÀRL
ROUTE DE PERREUX 1, BOUDRY, 2017, SWITZERLAND
Covered Properties
(2)
Bispecific Antibody Against Bcma and CD3 and an Immunological Drug for Combined Use in Treating Multiple Myeloma
Application:
17/304,683 →
Publication:
US 2022/0017631
Bispecific Antibody Against Bcma and CD3 and an Immunological Drug for Combined Use in Treating Multiple Myeloma
Application:
17/304,702 →
Publication:
US 2022/0002427
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 1, 2021
From: PAIVA, BRUNO DAVID LOURENCO; SAN MIGUEL IZQUIERDO, JESUS F.
To: UNIVERSIDAD DE NAVARRA
Reel/Frame 057986/0193 →
Nunc Pro Tunc Assignment
Apr 17, 2023
From: ENGMAB SÀRL
To: ENGMAB BETA HOLDINGS LLC
Reel/Frame 063353/0350 →
Nunc Pro Tunc Assignment
Apr 17, 2023
From: ENGMAB BETA HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 063353/0610 →
Assignment of Assignor's Interest
Apr 15, 2024
From: UNIVERSIDAD DE NAVARRA
To: ENGMAB SÀRL
Reel/Frame 067108/0905 →